Enhanced p53 Levels Are Involved in the Reduced Mineralization Capacity of Osteoblasts Derived from Shwachman-Diamond

Annalisa Frattini1,2, Simona Bolamperti3, Roberto Valli2

  • 1Institute for Genetic and Biomedical Research (IRGB), UOS Milano CNR, Via Fantoli, 15/16, 20138 Milano, Italy.

Insights

Shwachman-Diamond syndrome (SDS) impairs osteoblast function, reducing bone mineralization. This is linked to high p53 levels, an osteogenesis inhibitor, and reduced SBDS protein, crucial for ribosome biogenesis and bone cell activity.

Area of Science:

  • Genetics and Molecular Biology
  • Cell Biology
  • Orthopedics

Background:

  • Shwachman-Diamond syndrome (SDS) is a rare genetic disorder.
  • SDS is caused by mutations in the SBDS gene, affecting ribosome biogenesis.
  • SDS patients exhibit bone marrow failure, pancreatic insufficiency, and skeletal abnormalities.

Purpose of the Study:

  • To investigate the role of SBDS in osteoblast function and bone mineralization.
  • To explore the molecular mechanisms underlying skeletal abnormalities in SDS patients.
  • To identify potential therapeutic targets for SDS-related bone complications.

Main Methods:

  • Analysis of osteoblasts from SDS patients (SDS-OBs) and healthy subjects (H-OBs).
  • Assessment of SBDS gene and protein expression.
  • Evaluation of osteoblast mineralization capacity in vitro.
  • Whole transcriptome analysis to identify differentially expressed genes.
  • Western blot analysis to confirm protein expression levels.
  • TP53 gene silencing in SDS-OBs.

Main Results:

  • SDS-OBs showed reduced SBDS expression and lower mineralization capacity compared to H-OBs.
  • Transcriptome analysis revealed significant downregulation of osteoblastogenesis genes in SDS-OBs.
  • SDS-OBs exhibited lower levels of alkaline phosphatase and collagen type I.
  • Elevated p53 protein levels were observed in SDS-OBs, inhibiting osteogenesis.
  • TP53 silencing in SDS-OBs restored collagen type I and alkaline phosphatase levels and increased mineralization.

Conclusions:

  • Reduced bone mineralization in SDS is partly mediated by elevated p53 levels.
  • SBDS plays a critical role in osteoblast function and bone formation.
  • Targeting p53 may offer a therapeutic strategy for skeletal abnormalities in SDS.

Related Concept Videos

Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
4.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.7K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.3K